. 2023 May 31;10:1151575. doi: 10.3389/fcvm.2023.1151575

Table 2.

Prevalence and trend of AF in health check-up population in China between 2012 and 2017.

	2012	2013	2014	2015	2016	2017	Overall	2012–2017 APC [95%CI]
	NO.	NO.	NO.	NO.	NO.	NO.	NO.
	Prevalence	Prevalence	Prevalence	Prevalence	Prevalence	Prevalence	Prevalence
	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]
Total ^*
	526,550	555,905	593,699	634,888	548,877	189,259	30,49,178	−1.01 [−4.25,2.33]
	0.43% [0.41%,0.45%]	0.42% [0.40%,0.43%]	0.46% [0.44%,0.47%]	0.44% [0.42%,0.45%]	0.42% [0.41%,0.44%]	0.40% [0.37%,0.42%]	0.43% [0.42%,0.44%]	−1.01 [−4.25,2.33]
Age groups ^†
35–44	187,274	193,032	202,149	204,703	176,509	54,069	10,17,736	15.16 [6.42,24.62]
35–44	0.02% [0.02%,0.03%]	0.03% [0.02%,0.04%]	0.03% [0.02%,0.03%]	0.03% [0.03%,0.04%]	0.04% [0.03%,0.04%]	0.05% [0.03%,0.07%]	0.03% [0.03%,0.03%]	15.16 [6.42,24.62]
45–54	163,077	177,905	195,727	214,839	198,508	68,286	10,18,342	−1.72 [−7.88,4.86]
45–54	0.14% [0.12%,0.16%]	0.11% [0.09%,0.12%]	0.11% [0.10%,0.13%]	0.11% [0.10%,0.12%]	0.12% [0.11%,0.14%]	0.12% [0.10%,0.15%]	0.12% [0.11%,0.12%]	−1.72 [−7.88,4.86]
55–65	105,861	112,018	119,318	126,859	105,283	39,352	608,691	−3.31 [−7.76,1.36]
55–65	0.40% [0.36%,0.44%]	0.38% [0.34%,0.42%]	0.39% [0.35%,0.42%]	0.40% [0.36%,0.43%]	0.37% [0.33%,0.40%]	0.31% [0.25%,0.36%]	0.38% [0.36%,0.39%]	−3.31 [−7.76,1.36]
≥65	70,338	72,950	76,505	88,487	68,577	27,552	404,409	−1.01 [−5.57,3.77]
≥65	1.67% [1.58%,1.77%]	1.70% [1.60%,1.79%]	1.88% [1.78%,1.98%]	1.80% [1.72%,1.89%]	1.69% [1.59%,1.79%]	1.57% [1.42%,1.71%]	1.74% [1.70%,1.78%]	−1.01 [−5.57,3.77]
Region ^‡
Southern	316,764	314,070	344,211	360,716	322,381	76,993	17,35,135	2.34 [−1.27,6.09]
Southern	0.39% [0.36%,0.41%]	0.36% [0.34%,0.38%]	0.43% [0.41%,0.45%]	0.43% [0.41%,0.45%]	0.42% [0.40%,0.44%]	0.42% [0.37%,0.47%]	0.41% [0.40%,0.42%]	2.34 [−1.27,6.09]
Northern	209,786	241,835	249,488	274,172	226,496	112,266	13,14,043	−4.88 [−8.93,−0.66]
Northern	0.48% [0.45%,0.51%]	0.49% [0.46%,0.51%]	0.50% [0.47%,0.52%]	0.44% [0.42%,0.47%]	0.43% [0.40%,0.45%]	0.36% [0.33%,0.40%]	0.46% [0.45%,0.47%]	−4.88 [−8.93,−0.66]
Sex ^§
Male	314,250	330,362	355,224	374,781	327,002	109,814	18,11,433	−0.80 [−3.86,2.36]
Male	0.50% [0.48%,0.53%]	0.49% [0.46%,0.51%]	0.53% [0.50%,0.55%]	0.51% [0.49%,0.54%]	0.51% [0.48%,0.53%]	0.46% [0.42%,0.50%]	0.51% [0.50%,0.52%]	−0.80 [−3.86,2.36]
Female	212,300	225,543	238,475	260,107	221,875	79,445	12,37,745	−1.31 [−5.24,2.78]
Female	0.35% [0.32%,0.37%]	0.34% [0.32%,0.37%]	0.38% [0.36%,0.41%]	0.35% [0.33%,0.38%]	0.34% [0.31%,0.36%]	0.33% [0.29%,0.37%]	0.35% [0.34%,0.36%]	−1.31 [−5.24,2.78]

AF, atrial fibrillation; CI, confidence interval; APC, annual percentage change.

Prevalence of AF in China was standardized by age, sex, and region.

^{^†}

Prevalence of AF in different age groups was standardized by sex and region.

^{^‡}

Prevalence of AF in southern and northern China was standardized by age and sex.

^{^§}

Prevalence of AF in male and female were standardized by age and region.